Cleveland-Cliffs
CLF
12.06
-0.19
-1.55%
Cleveland-Cliffs
US · CLF
#1860 by market cap
Listed 2016
12.06
-0.19
-1.55%
Live - 5344 symbols - heartbeat 171s ago
· 2026-10-08 07:39
Pre-market
11.89
-1.41%
After-hours
12.17
+0.91%
- Market cap
- 6.88B
- P/E (TTM)i
- -7.58
- P/Bi
- 1.23
- EPSi
- -2.91
- Div yieldi
- 0.00%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on CLF?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Hold
Avg price target
12.44 +3.2%
Price target rangecurrent 12.06
Low10.00
Avg12.44
High17.48
Buy 11%
Hold 78%
Sell 11%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | Morgan Stanley | -- | HOLD | 12.50 |
| 2026-09-21 | GLJ Research | -- | BUY | 17.48 |
| 2026-09-09 | J.P. Morgan | -- | HOLD | 13.00 |
| 2026-09-06 | BofA Securities | -- | HOLD | 13.00 |
| 2026-08-26 | Wells Fargo | -- | HOLD | 12.00 |
| 2026-08-24 | Wells Fargo | -- | HOLD | 12.00 |
| 2026-08-24 | Barclays | -- | SELL | 10.00 |
| 2026-08-03 | BofA Securities | -- | HOLD | 12.00 |
| 2026-07-28 | KeyBanc | -- | HOLD | -- |
| 2026-07-24 | BNP Paribas | -- | HOLD | 11.50 |
| 2026-07-24 | Wells Fargo | -- | HOLD | 11.00 |
| 2026-07-24 | Morgan Stanley | -- | HOLD | 12.50 |
| 2026-07-24 | GLJ Research | -- | BUY | 15.60 |
| 2026-07-23 | Wells Fargo | -- | HOLD | 11.00 |
| 2026-07-23 | BofA Securities | -- | HOLD | 11.50 |
| 2026-07-19 | J.P. Morgan | -- | HOLD | 10.00 |
| 2026-07-16 | Barclays | -- | SELL | 9.00 |
| 2026-07-15 | Barclays | -- | SELL | 9.00 |
| 2026-07-15 | J.P. Morgan | -- | HOLD | 10.00 |
| 2026-07-12 | J.P. Morgan | -- | HOLD | 13.00 |
| 2026-07-08 | BofA Securities | -- | HOLD | 11.50 |
| 2026-07-07 | Citi | -- | HOLD | 10.00 |
| 2026-07-05 | Goldman Sachs | -- | HOLD | 10.00 |
| 2026-06-30 | Wells Fargo | -- | HOLD | 14.00 |
| 2026-06-22 | Morgan Stanley | -- | HOLD | 12.50 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Hold
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
4 3
■ Upgrades■ Downgrades
- 4 upgrades vs 3 downgrades among tracked analyst rating changes.
- Most recent: GLJ Research moved from Hold to Buy on 2026-07-24.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-24 | GLJ Research | HOLD → BUY | 15.60 |
| 2026-07-05 | Goldman Sachs | BUY → HOLD | 10.00 |
| 2026-06-22 | Morgan Stanley | BUY → HOLD | 12.50 |
| 2026-06-09 | GLJ Research | SELL → HOLD | 15.01 |
| 2026-03-25 | KeyBanc | BUY → HOLD | -- |
| 2026-01-09 | Morgan Stanley | HOLD → BUY | 17.00 |
| 2025-11-14 | Wells Fargo | SELL → HOLD | 12.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-23 | -- | ±9.96% | +15.98% (beat) |
| 2026/Q1 | 2026-04-20 | -- | ±9.74% | -2.11% (in line) |
| 2025/Q4 | 2026-02-09 | -- | ±10.76% | -16.43% (beat) |
| 2025/Q3 | 2025-10-20 | -- | ±8.81% | +21.47% (beat) |
| 2025/Q2 | 2025-07-21 | -- | ±9.58% | +12.45% (beat) |
| 2025/Q1 | 2025-05-07 | After close | ±9.88% | -15.78% (beat) |
| 2024/Q4 | 2025-02-24 | After close | ±8.39% | -3.23% (in line) |
| 2024/Q3 | 2024-11-04 | After close | ±11.20% | -11.44% (beat) |
| 2024/Q2 | 2024-07-22 | After close | ±7.96% | +4.41% (in line) |
| 2024/Q1 | 2024-04-22 | After close | ±7.44% | -11.03% (beat) |
| 2023/Q4 | 2024-01-29 | After close | ±7.05% | +6.56% (in line) |
| 2023/Q3 | 2023-10-23 | After close | ±7.78% | +8.91% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:39:22 · For reference only, not investment advice and not tailored to your situation.